These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1167821)

  • 1. Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.
    Cope CL; Loizou S
    Clin Sci Mol Med; 1975 Feb; 48(2):97-105. PubMed ID: 1167821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE; Holland OB; Upcavage R
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT; Wilson TE; Melby JC
    Hypertension; 1985; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
    Ehlers ME; Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
    Cassar J; Loizou S; Kelly WF; Mashiter K; Joplin GF
    Metabolism; 1980 Feb; 29(2):115-9. PubMed ID: 7354720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythms of urinary sodium, potassium and some agents influencing their excretion in young borderline hypertensives.
    Bultasová H; Veselková A; Brodan V; Pinsker P
    Endocrinol Exp; 1986 Dec; 20(4):359-69. PubMed ID: 3492363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of plasma 11-deoxycorticosterone, 18-hydroxy-11-deoxycorticosterone, and aldosterone in man.
    Ojima M; Aida M; Kambegawa A
    Tohoku J Exp Med; 1978 Apr; 124(4):367-79. PubMed ID: 663934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Hypertension; 1983; 5(3):385-9. PubMed ID: 6341221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
    Adam WR
    Clin Sci (Lond); 1986 Oct; 71(4):375-83. PubMed ID: 3757436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 19-nor-deoxycorticosterone and deoxycorticosterone in hypertensive disease of pregnancy.
    Shah DM; Gomez-Sanchez CE; Knuppel RA; Vaughn WK
    Am J Perinatol; 1987 Apr; 4(2):102-5. PubMed ID: 3566877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metoprolol on 24-hour urinary excretion of adrenal steroids and kallikrein in patients with essential hypertension.
    Fritschka E; Gotzen R; Kittler R; Schöneshöfer M
    Br J Pharmacol; 1984 Feb; 81(2):245-53. PubMed ID: 6367871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for urinary free 19-nor-deoxycorticosterone: effects of adrenocorticotropin and sodium depletion.
    Gomez-Sanchez CE; Gomez-Sanchez EP; Upcavage RJ
    Endocrinology; 1983 Jun; 112(6):2046-9. PubMed ID: 6303757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man.
    Williams GH; Braley LM; Underwood RH
    J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I; Yamada T; Aizawa T; Takasu N; Niwa A; Maruyama Y; Ogawa A
    Cardiology; 1991; 78(2):99-110. PubMed ID: 2070375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 19-nor-deoxycorticosterone excretion in healthy and hypertensive subjects.
    Griffing GT; Dale SL; Holbrook MM; Melby JC
    Trans Assoc Am Physicians; 1981; 94():301-9. PubMed ID: 6283708
    [No Abstract]   [Full Text] [Related]  

  • 19. DOCA test for aldosteronism: its usefulness and implications.
    Rodríguez JA; Lopez JM; Biglieri EG
    Hypertension; 1981; 3(6 Pt 2):II-102-6. PubMed ID: 7028610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19-Nordeoxycorticosterone excretion in male and female inbred salt-sensitive (S/JR) and salt-resistant (R/JR) Dahl rats.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Endocrinology; 1988 Mar; 122(3):1110-3. PubMed ID: 3342746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.